As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is one of the most lethal malignancies in the urinary system and the existing immunotherapy has not achieved satisfactory outcomes. Therefore, this study aims at establishing a novel gene signature for immune infiltration and clinical outcome (over...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Daojia, Shi, Jian, Xiong, Zhiyong, Xiao, Wen, Meng, Xiangui, Lv, Qingyang, Xie, Kairu, Yang, Hongmei, Zhang, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822671/
https://www.ncbi.nlm.nih.gov/pubmed/35135552
http://dx.doi.org/10.1186/s12935-022-02480-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822671/
https://www.ncbi.nlm.nih.gov/pubmed/35135552
http://dx.doi.org/10.1186/s12935-022-02480-7

Ejemplares similares